202336-25-2

Basic information

• Product Name: [2-(4-hydroxyphenyl)-6-hydroxybenzo[b]thien-3-yl] [4-fluorophenyl]methanone
• Synonyms: [2-(4-hydroxyphenyl)-6-hydroxybenzo[b]thien-3-yl] [4-fluorophenyl]methanone
• CAS NO: 202336-25-2
• Molecular Weight: 364.397
• Mol File: 202336-25-2.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: [2-(4-hydroxyphenyl)-6-hydroxybenzo[b]thien-3-yl] [4-fluorophenyl]methanone(CAS DataBase Reference)
• NIST Chemistry Reference: [2-(4-hydroxyphenyl)-6-hydroxybenzo[b]thien-3-yl] [4-fluorophenyl]methanone(202336-25-2)
• EPA Substance Registry System: [2-(4-hydroxyphenyl)-6-hydroxybenzo[b]thien-3-yl] [4-fluorophenyl]methanone(202336-25-2)

Safety Data

• Hazardous Substances Data: 202336-25-2(Hazardous Substances Data)

Upstream product

• 63675-74-1 2-(4'-methoxyphenyl)-6-methoxybenzothiophene 
• 403-43-0 4-fluorobenzoyl chloride 
• 206434-77-7 6-methoxy-2-(4-methoxyphenyl)-3-(4-fluorobenzoyl)benzo[b]thiophene 

Downstream Products

• 84449-90-1 Raloxifen 
• 1334677-22-3 Ral-N₃ 
• 1334677-29-0 C₄₆H₃₄N₆O₅S 

Relevant articles and documents

BENZOTHIOPHENE DERIVATIVES AS ESTROGEN RECEPTOR INHIBITORS

A compound of formula (I), or a pharmaceutically acceptable salt thereof, compositions, combinations and medicaments containing said compounds and processes for their preparation. The invention also relates to the use of said compounds, combinations, compositions and medicaments, for example as inhibitors of the activity of the estrogen receptor, including degrading the estrogen receptor, the treatment of diseases and conditions mediated by the estrogen receptor.

Benzothiophene compounds, and uses formulations thereof

Benzothiophenes, and uses and formulations thereof, are provided by the present invention.